New Leaf Venture Partners, L.L.C. Edgewise Therapeutics, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $44.5 Million
- Q1 2025
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 1,030,161 shares of EWTX stock, worth $14.8 Million. This represents 50.97% of its overall portfolio holdings.
Number of Shares
1,030,161
Previous 1,030,161
-0.0%
Holding current value
$14.8 Million
Previous $27.5 Million
17.6%
% of portfolio
50.97%
Previous 37.07%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$215 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$128 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$93.8 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$88.2 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$86.1 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $905M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...